Biofrontera (BFRI) Net Margin (2020 - 2025)
Biofrontera's (BFRI) quarterly Net Margin came in at 46.04% in Q4 2025, up 5715.0% year-on-year from 0.79% in Q4 2024, and up 148.38% quarter-over-quarter from 95.15% in Q3 2025.
Biofrontera (BFRI) Net Margin (2020 - 2025) Analysis & Trends
Biofrontera's Net Margin history runs 6 years deep, the most recent figure standing at 46.04% for Q4 2025.
- On a quarterly basis, Net Margin rose 5715.0% year-over-year to 46.04% in Q4 2025; TTM through Dec 2025 was 19.91%, a 2767.0% increase from a year earlier, with the FY2025 full-year figure at 19.91%, up 2767.0% from the prior year.
- Net Margin advanced to 46.04% in Q4 2025 per BFRI's latest filing, from 95.15% in the prior quarter.
- Across five years, Net Margin topped out at 97.51% in Q4 2021 and bottomed at 369.45% in Q3 2021.
- The 5-year median for Net Margin is 59.16% (2022), against an average of 55.8%.
- Across the five-year window, Net Margin plunged 27766 bps in 2021 and jumped 31008 bps in 2022, its largest moves.
- Year by year, Net Margin stood at 97.51% in 2021, then tumbled by 128 bps to 27.45% in 2022, then soared by 221 bps to 33.28% in 2023, then tumbled by 133 bps to 11.12% in 2024, then jumped by 514 bps to 46.04% in 2025.
- Per Business Quant, the three latest BFRI Net Margin figures stand at 46.04% (Q4 2025), 95.15% (Q3 2025), and 58.96% (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 9.29% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 26.57% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -33.66% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 35.18% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 5.03% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 24.30% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 4.16% |
| 10 | Biofrontera | 12.70 Mn | 6.29 Mn | 14.09 Mn | 46.04% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 46.04% |
| Sep 30, 2025 | -95.15% |
| Jun 30, 2025 | -58.96% |
| Mar 31, 2025 | -48.94% |
| Dec 31, 2024 | -11.12% |
| Sep 30, 2024 | -62.91% |
| Jun 30, 2024 | -3.28% |
| Mar 31, 2024 | -131.91% |
| Dec 31, 2023 | 33.28% |
| Sep 30, 2023 | -71.29% |
| Jun 30, 2023 | -168.21% |
| Mar 31, 2023 | -85.63% |
| Dec 31, 2022 | -27.45% |
| Sep 30, 2022 | -59.37% |
| Jun 30, 2022 | -19.07% |
| Mar 31, 2022 | 57.03% |
| Dec 31, 2021 | 97.51% |
| Sep 30, 2021 | -369.45% |
| Jun 30, 2021 | -62.53% |
| Mar 31, 2021 | -74.49% |